| View |
|
DRP-10000
|
Montelukast (As Sodium)
|
Montezyd 10
|
10mg
|
Film Coated Tablet
|
Leukotriene receptor antagonist
|
Cadila Healthcare Limited
|
India
|
-
|
13 January 2022
|
27 February 2027
|
| View |
|
DRP-8509
|
Tramadol Hydrochloride
|
Tramal
|
100 mg
|
Retard Tablet
|
Opioid Analgesic
|
Farmaceutici Foramen S.P.A.
|
Italy
|
Renewal (PCPR)
|
20 January 2022
|
03 March 2027
|
| View |
|
HRP-444
|
2,4-Dichlorobenzyl Alcohol + Amylmetacresol
|
Therasil (Honey and Lemon flavor)
|
1.2 mg/600 mcg
|
Lozenge
|
Antiseptic
|
Plethico Pharmaceuticals Limited
|
India
|
Renewal
|
08 February 2022
|
24 April 2027
|
| View |
|
DR-XY40905
|
Sildenafil (As Citrate)
|
Greatafil
|
50 mg
|
Film-Coated Tablet
|
Phosphodiesterase Type-5 Inhibitor
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal (Compliance)
|
09 February 2022
|
18 May 2027
|
| View |
|
DRP-258
|
Paracetamol
|
Freever
|
250mg/5mL
|
Syrup
|
Analgesic/Antipyretic
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
-
|
07 January 2022
|
11 June 2027
|
| View |
|
DRP-3689-03
|
Cetirizine Dihydrochloride
|
None
|
10 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Zim Laboratories Ltd.
|
India
|
-
|
01 November 2021
|
27 March 2027
|
| View |
|
HRP-446
|
2,4-Dichlorobenzyl Alcohol + Amylmetacresol
|
Therasil (Black Currant Flavor)
|
1.2 mg/600 mcg
|
Lozenge
|
Antiseptic
|
Plethico Pharmaceuticals Limited
|
India
|
Renewal
|
08 February 2022
|
09 May 2027
|
| View |
|
DR-XY47054
|
Bisoprolol Fumarate
|
Biscore 5
|
5 mg
|
Film Coated Tablet
|
Beta-Adrenoceptor Receptor Blocker
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Initial (Variation)
|
14 September 2020
|
14 September 2025
|
| View |
|
DR-XY47702
|
Telmisartan + Hydrochlorothiazide
|
ARB Plus
|
40 mg/ 12.5 mg
|
Film-Coated Tablet
|
-
|
Corona Remedies Private Limited
|
India
|
-
|
31 January 2022
|
31 January 2027
|
| View |
|
BR-1386
|
Bevacizumab
|
Avamab
|
100 mg/4 mL (25 mg/mL)
|
Concentrate for Solution for Infusion (IV)
|
-
|
Sinergium Biotech S.A.
|
Argentine Republic
|
-
|
02 February 2022
|
02 February 2027
|
| View |
|
BR-1385
|
Bevacizumab
|
Avamab
|
400 mg/16 mL (25 mg/mL)
|
Concentrate for Solution for Infusion (IV)
|
VEGF/VEGFR (Vascular Endothelial Growth Factor) Inhibitors
|
Sinergium Biotech S.A.
|
Argentine Republic
|
Monitored Release
|
02 February 2022
|
02 February 2027
|
| View |
|
DRP-3100-02
|
Cinnarizine
|
Lorizine
|
25 mg
|
Tablet
|
Anti-Vertigo
|
XL Laboratories Pvt Ltd
|
India
|
Renewal
|
21 March 2024
|
05 July 2029
|
| View |
DRP-11198_PI_01.pdf
|
DRP-11198
|
Sitagliptin (as phosphate monohydrate)
|
None
|
25 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
11 February 2022
|
11 February 2027
|
| View |
|
BRP-105
|
Epoetin Alfa
|
Eposis
|
4000IU/0.4mL
|
Solution For Injection (I.V/S.C)
|
Antianemics
|
Daewong Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
04 April 2022
|
07 May 2027
|
| View |
DRP-11121_PI_01.pdf
|
DRP-11121
|
Vortioxetine (As Hydrobromide)
|
Brintellix
|
5 mg
|
Film-Coated Tablet
|
-
|
H. Lundbeck A/S
|
Denmark
|
-
|
04 February 2022
|
29 June 2025
|
| View |
DRP-11122_PI_01.pdf
|
DRP-11122
|
Vortioxetine (As Hydrobromide)
|
Brintellix
|
10 mg
|
Film-Coated Tablet
|
Antidepressant
|
H. Lundbeck A/S
|
Denmark
|
Initial
|
04 February 2022
|
29 June 2025
|
| View |
DRP-11123_PI_01.pdf
|
DRP-11123
|
Vortioxetine (As Hydrobromide)
|
Brintellix
|
15 mg
|
Film-Coated Tablet
|
-
|
H. Lundbeck A/S
|
Denmark
|
-
|
04 February 2022
|
29 June 2025
|
| View |
DRP-11124_PI_01.pdf
|
DRP-11124
|
Vortioxetine (As Hydrobromide)
|
Brintellix
|
20 mg
|
Film-Coated Tablet
|
-
|
H. Lundbeck A/S
|
Denmark
|
-
|
04 February 2022
|
29 June 2025
|
| View |
|
DRP-11105
|
Ceftriaxone (as sodium) + Sulbactam (as sodium)
|
Viriaxone
|
1 g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin/Beta-Lactamase
Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
31 January 2022
|
31 January 2027
|
| View |
|
DR-XY47708
|
Etoricoxib
|
Ebicox 90
|
90 mg
|
Film-Coated Tablet
|
Selective Cox-2 Inhibitor (Non-Steroidal Anti inflammatory Drug/Antirheumatic Drug)
|
Biolab Co., Ltd.
|
Thailand
|
Initial
|
08 February 2022
|
08 February 2027
|